You need to enable JavaScript to run this app.
FDA finalizes guidance on therapeutic protein biosimilars
Regulatory News
Ferdous Al-Faruque
Biologics/ biosimilars/ vaccines
CBER
Guidance
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)